Landmark Gift Of $100 Million From The Marie-Josée And Henry R. Kravis Foundation Will Support Groundbreaking Approach To Precision Oncology At Memorial Sloan-Kettering Cancer Center
5/20/2014 10:14:08 AM
NEW YORK--(BUSINESS WIRE)--Memorial Sloan Kettering Cancer Center (MSK) today launched an ambitious initiative to improve cancer care and research through genomic analysis. The new program will reshape clinical trials and speed the translation of novel molecular discoveries into routine clinical practice. The Marie-Josée and Henry R. Kravis Center for Molecular Oncology (CMO) is named in honor of Marie-Josée and Henry R. Kravis, whose transformative gift of $100 million will make it possible to realize the promise of precision oncology and support the development of new, individualized cancer therapies and diagnostic tools.
Help employers find you! Check out all the jobs and post your resume.
comments powered by